Entero Healthcare Solutions DuPont analysis

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.80×0.81×0.77×1.12×—
0.79×0.81×0.98×0.41×—
3.7%3.4%2.8%2.2%—
2.09×2.09×2.02×2.15×—
2.05×2.05×1.53×1.43×2.19×
10.1%9.5%6.5%3.1%—
6.7%6.7%5.6%3.5%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ENTERO₹1,470.00

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹6,396 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×—1.120.770.810.80
Interest Burden (Pretax/EBIT) ×—0.410.980.810.79
EBIT Margin %—2.212.763.383.73
Asset Turnover ×—2.152.022.092.09
Financial Leverage (Assets/Equity) ×2.191.431.532.052.05
ROE (5-step product, year-end total equity) %—3.126.509.5010.10
ROE (owners' profit / average owners' equity) %—3.505.646.746.74
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.